ribavirin has been researched along with Carditis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| An, XJ; Gao, J; Jia, LB; Li, CL; Wang, ZZ | 1 |
| Cameli, M; Cameli, P; Franchi, F; Mandoli, GE; Menci, D; Mondillo, S; Sciaccaluga, C; Sisti, N; Valente, S | 1 |
| Gao, B; He, X; Xiong, S; Zhou, L | 1 |
| Jiang, Y; Luo, H; Luo, L; Mu, Q; Shen, X; Zhu, R; Zhu, Y; Zou, X | 1 |
| Cumaraswamy, S; Hou, Y; Kalimuddin, S; Lai, SH; Low, CY; Ooi, EE; Sessions, OM; Sim, D; Tan, TE | 1 |
| Chen, J; Hui, R; Liu, Z; Shi, Y; Song, X; Wang, H; Wang, X; Xin, Y; Zhang, C | 1 |
| Figulla, HR; Grumbach, I; Heim, A; Kandolf, R; Müller, G; Pring-Akerblom, P; Stille-Siegener, M | 1 |
| Copeland, JG; Grogan, TM; Icenogle, TB; Minnich, LL; Ray, CG | 1 |
| Abelmann, WH; Crumpacker, CS; Kawai, C; Matsumori, A | 1 |
| Abelmann, WH; Crumpacker, CS; Kishimoto, C | 1 |
| Abelmann, WH; Crumpacker, CS; Matsumori, A; Wang, H | 1 |
1 review(s) available for ribavirin and Carditis
| Article | Year |
|---|---|
COVID-19 and the burning issue of drug interaction: never forget the ECG.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arrhythmias, Cardiac; Chloroquine; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Electrocardiography; Heart Failure; Humans; Hydroxychloroquine; Hypoxia; Inflammation; Long QT Syndrome; Lopinavir; Myocarditis; Myocardium; Precipitating Factors; Receptors, Interleukin-6; Respiratory Distress Syndrome; Ribavirin; Ritonavir; SARS-CoV-2; Water-Electrolyte Imbalance | 2021 |
10 other study(ies) available for ribavirin and Carditis
| Article | Year |
|---|---|
The efficacy observation of ulinastatin combined with creatine phosphate sodium in pediatric viral myocarditis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Glycoproteins; Humans; Male; Myocarditis; Phosphocreatine; Retrospective Studies; Ribavirin; Virus Diseases | 2019 |
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Topics: Androstadienes; Animals; Antiviral Agents; Apoptosis; Autophagy-Related Protein 5; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Myocarditis; Myocardium; Phagosomes; Ribavirin; RNA, Small Interfering; Virus Replication; Vorinostat; Wortmannin | 2015 |
Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Topics: Animals; Antiviral Agents; beta-Defensins; Cell Survival; Coxsackievirus Infections; Enterovirus B, Human; Female; HeLa Cells; Humans; Inflammation; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Recombinant Proteins; Ribavirin; Virus Replication | 2015 |
Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis.
Topics: Administration, Intravenous; Antiviral Agents; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Molecular Sequence Data; Myocarditis; Parainfluenza Virus 2, Human; Ribavirin; RNA, Viral; Rubulavirus Infections; Sequence Analysis, DNA; Treatment Outcome | 2013 |
QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coxsackievirus Infections; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Enterovirus B, Human; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Myocarditis; Necrosis; Ribavirin; Vero Cells; Virus Attachment; Virus Internalization | 2007 |
Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha.
Topics: Antiviral Agents; Carrier State; Cell Line; Coxsackievirus Infections; Drug Synergism; Enterovirus B, Human; Fibroblasts; Humans; Interferon-alpha; Myocarditis; Myocardium; Ribavirin | 1997 |
The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis.
Topics: Acute Disease; Adult; Child, Preschool; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Infusions, Intravenous; Myocarditis; Myocardium; Ribavirin; Ribonucleosides | 1989 |
Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus.
Topics: Animals; Autoantibodies; Cardiomyopathy, Dilated; Disease Models, Animal; Encephalomyocarditis virus; Endomyocardial Fibrosis; Enterovirus Infections; Immunity, Maternally-Acquired; Interferon Type I; Isoenzymes; Mice; Mice, Inbred DBA; Myocarditis; Myocardium; Myosins; Recombinant Proteins; Ribavirin; Viral Vaccines | 1987 |
Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Fluorescent Antibody Technique; Lymphocytes; Male; Mice; Myocarditis; Ribavirin; Ribonucleosides; Spleen; Viral Plaque Assay | 1988 |
Treatment of viral myocarditis with ribavirin in an animal preparation.
Topics: Animals; Encephalomyocarditis virus; Enterovirus Infections; Heart; Male; Mice; Mice, Inbred DBA; Myocarditis; Ribavirin; Ribonucleosides | 1985 |